Dimensional Fund Advisors LP
- SEC CIK
- 0000354204
- Latest filing
- Aug 11, 2026
GANX holding history
Gain Therapeutics, Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GANX overviewAll 13F holders of GANXFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −15,886−100.0% | Sold out | Holders |
| Q4 2023 | 15,886 | $51.9K | <0.1% | −933−5.5% | Reduced | Holders |
| Q3 2023 | 16,819 | $54.3K | <0.1% | −4,143−19.8% | Reduced | Holders |
| Q2 2023 | 20,962 | $93.9K | <0.1% | +2,355+12.7% | Added | Holders |
| Q1 2023 | 18,607 | $89.7K | <0.1% | +6,661+55.8% | Added | Holders |
| Q4 2022 | 11,946 | $37.0K | <0.1% | +40.0% | Added | Holders |
| Q3 2022 | 11,942 | $39.0K | <0.1% | +11,942 | New | Holders |